RxDoctor Payments DataLook up a doctor →

KISQALI: payments to doctors

Payments that named KISQALI as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$8.8M
Providers
13,726
Transactions
116,337
Average per transaction
$76

The per-transaction average — $76 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 13,726 providers the average total is $642, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis$8,741,64099.1%
Novartis Pharma AG$76,2910.9%
← All drugs & devices